

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
ACRS
Aclaris Therapeutics
$2.18
Strengths

Upgraded on attractively valued
Chart
$1.99 (+9.55%)
$1.54 (+41.56%)
$1.47 (+48.30%)
$2.26 (-3.54%)
ACRS has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

ACRS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
ACRS Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ACRS Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayACRS Earnings
The TTM reflects 12-month period, providing review of ACRS financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
SNY
51.79
+4.44%
PFE
24.77
+0.36%
LLY
830.11
+1.10%
ABBV
227.89
-0.18%
What is ACRS current stock price?
What are ACRS stock strengths?
What risks are associated with ACRS stock?
When is ACRS next earnings report?
What is ACRS market cap and volume?
What is ACRS's current Stock IQ?
Should I buy ACRS stock right now?
Is ACRS a Strong Buy right now?
What does a 'Strong Buy' rating mean for ACRS?
What does a 'Strong Sell' rating mean for ACRS?
What factors influence ACRS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
ACRS
Aclaris Therapeutics
Current Price
$2.18
Stock Insights
Strengths

Upgraded on attractively valued
Linked to ACRS
SNY
51.79
+4.44%
PFE
24.77
+0.36%
LLY
830.11
+1.10%
ABBV
227.89
-0.18%
Chart
$1.99 (+9.55%)
$1.54 (+41.56%)
$1.47 (+48.30%)
$2.26 (-3.54%)
ACRS Analysts Opinion
ACRS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
ACRS Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ACRS Street view is extremely bullish and have negative views on the near-term outlook
ACRS has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels.
ACRS Earnings
The TTM data reflects the most recent 12-month period, providing overview of ACRS financial performance.
ACRS Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
ACRS Latest Analysis
What Makes Aclaris Therapeutics (ACRS) a Strong Momentum Stock: Buy Now?. Does Aclaris Therapeutics (ACRS) have what it takes to be a top stock pick for momentum investors? Lets find out.
Tue Oct 21, 2025
HC Wainwright & Co. Reiterates Aclaris Therapeutics (ACRS) Buy Recommendation. Fintel reports that on October 20 2025 HC Wainwright &. Co. reiterated coverage of Aclaris Therapeutics (NasdaqGS:ACRS) with a Buy recommendation. Analyst Price Forecast Suggests 321.80% Upside
Mon Oct 20, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ACRS Stock trends
ACRS Stock performance
ACRS Stock analysis
ACRS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.